Characterization of the transport of uracil across Caco-2 and LLC-PK1 cell monolayers

被引:15
|
作者
Li, H [1 ]
Chung, SJ [1 ]
Shim, CK [1 ]
机构
[1] Seoul Natl Univ, Dept Pharmaceut, Coll Pharm, Seoul 151742, South Korea
关键词
uracil; pyrimidine nucleobase; transport; Caco-2; LLC-PK1;
D O I
10.1023/A:1020456632737
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this study was to characterize the transport of uracil, a pyrimidine nucleobase, in Caco-2 and LLC-PK1 cells. Methods. Caco-2 and LLC-PK1 cells were grown to confluency on a permeable polycarbonate membrane insert to permit transport and uptake experiments after the loading of uracil on either the apical or basolateral side. Results. The vectorial transport of uracil in both directions was saturable with comparable K-m and V-max in Caco-2 cell monolayers, probably because of a Na+-independent transport system located on the basolateral membrane. In LLC-PK1 cell monolayers, two distinct transport systems, namely a Na+-dependent and a Na+-independent, were functional in the apical to basolateral (A-B) transport of uracil. The first system was saturable with a K-m value of 3.67 +/- 0.40 muM, a V-max of 11.31 +/- 0.91 pmol/cm(2)/min, and a Na+:uracil coupling stoichiometry of 1.28 +/- 0.20. The second system was Na+ independent and satuable with a low affinity (K-m, 50.37 +/- 9.61 muM) and V-max (16.01 +/- 4.48 pmol/cm2/min). The two transport systems appeared to be located on the apical membrane. Conclusion. The mechanism of uracil transport differs depending on cell lines; a Na+-independent system on the basolateral membrane in Caco-2 cells and both Na+-dependent and Na+-independent systems on the apical membrane in LLC-PK1 cells seem to be responsible for the difference.
引用
收藏
页码:1495 / 1501
页数:7
相关论文
共 50 条
  • [41] Characterization of mefenamic acid-guaiacol ester: Stability and transport across Caco-2 cell monolayers
    Tantishaiyakul, V
    Wiwattanawongsa, K
    Pinsuwan, S
    Kasiwong, S
    Phadoongsombut, N
    Kaewnopparat, S
    Kaewnopparat, N
    Rojanasakul, Y
    PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 1013 - 1018
  • [42] Characterization of Mefenamic Acid-Guaiacol Ester: Stability and Transport Across Caco-2 Cell Monolayers
    Vimon Tantishaiyakul
    Kamonthip Wiwattanawongsa
    Sirirat Pinsuwan
    Srirat Kasiwong
    Narubodee Phadoongsombut
    Sanae Kaewnopparat
    Nattha Kaewnopparat
    Yon Rojanasakul
    Pharmaceutical Research, 2002, 19 : 1013 - 1018
  • [43] Assessment of P-gp, BCRP and MRP activity in Caco-2 and MDR1-LLC-PK1 cell monolayers
    Kapadnis, Sudarshan
    Perloff, Elke S.
    Khun, Wendy
    Fox, Lisa
    Crespi, Charles L.
    Stresser, David M.
    DRUG METABOLISM REVIEWS, 2009, 41 : 178 - 178
  • [44] Absorption of LysoTracker® across Caco-2 cell monolayers
    Xia, CQ
    Chuang, BC
    Gallegos, R
    Liu, N
    Gan, LS
    Miwa, G
    DRUG METABOLISM REVIEWS, 2004, 36 : 54 - 54
  • [45] Omeprazole decreases magnesium transport across Caco-2 monolayers
    Narongrit Thongon
    Nateetip Krishnamra
    World Journal of Gastroenterology, 2011, 17 (12) : 1574 - 1583
  • [46] Transport of paraquat in a renal epithelial cell line LLC-PK1
    Chan, BSH
    Lazzaro, VA
    Seale, JP
    Duggin, GG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (02): : 625 - 632
  • [47] Transport of hop aroma compounds across Caco-2 monolayers
    Heinlein, A.
    Metzger, M.
    Walles, H.
    Buettner, A.
    FOOD & FUNCTION, 2014, 5 (11) : 2719 - 2730
  • [48] Omeprazole decreases magnesium transport across Caco-2 monolayers
    Thongon, Narongrit
    Krishnamra, Nateetip
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (12) : 1574 - 1583
  • [49] TRANSPORT OF SALICYLIC-ACID THROUGH MONOLAYERS OF A KIDNEY EPITHELIAL-CELL LINE (LLC-PK1)
    CHATTON, JY
    ROCHRAMEL, F
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 261 (02): : 518 - 524
  • [50] Species difference of P-gp mediated drug transport across P-gp expressed LLC-PK1 cell monolayers
    Adachi, Y
    Guiney, D
    Ninomiya, S
    Sudo, T
    DRUG METABOLISM REVIEWS, 2003, 35 : 153 - 153